Bangladesh’s healthcare system is facing one of its gravest challenges in decades, as an alarming rise in deaths is being linked to the consumption of adulterated and counterfeit medicines. Health experts warn that the crisis is spiraling out of control, with fake drugs causing irreversible damage to patients’ kidneys, livers, and other vital organs - and in many cases, death.
Reports from across the country paint a deeply disturbing picture: life-saving medicines are being replaced by toxic, substandard copies, often indistinguishable from the real product. Many of these fake drugs are manufactured and distributed by an organized criminal syndicate operating out of Mitford, Old Dhaka - home to the largest medicine market in the nation.
The syndicate’s operations extend far beyond the capital, pushing counterfeit products into every corner of the country, from busy urban pharmacies to small rural dispensaries. Investigations suggest the gang is producing and marketing drugs under the guise of both reputable domestic brands and high-demand imported medicines. Even more troubling, there are allegations that certain officials within the Drug Administration - the bodies responsible for regulating pharmaceuticals - are colluding with the criminals. A Crime ‘Equivalent to Murder’: Medical professionals have been quick to denounce these activities. Some have gone so far as to call them “equivalent to murder,” given that the perpetrators knowingly endanger lives for profit. The scale of the problem is staggering. Nearly 90 percent of medicine outlets across Bangladesh operate without licensed pharmacists, despite laws requiring trained professionals to oversee the sale, storage, and distribution of drugs. Without such oversight, counterfeit medicines enter the supply chain with little resistance.
“Every day, patients are unknowingly ingesting substances that may contain no active ingredient at all - or worse, toxic chemicals,” said a senior doctor at Dhaka Medical College Hospital. “This is not just negligence; it is premeditated harm.”
Weak Enforcement and Corruption Allegations: Although the Drug Administration claims to be conducting regular crackdowns against counterfeiters, industry insiders say these actions are largely superficial. “There is enforcement on paper, but on the ground, the black market thrives,” said one veteran pharmacist in Chattogram.
Sources allege that certain leaders of the Chemist and Druggist Association, which represents pharmacy owners nationwide, have actively encouraged the sale of counterfeit products. In exchange, they receive bribes or commissions from traders dealing in fake drugs. This collusion, experts warn, has created a powerful protection network for counterfeiters, making it almost impossible for honest pharmacists to compete.
The Scope of the Counterfeit Market: The list of falsified medicines is long and deeply troubling. Essential treatments such as insulin for diabetes, antibiotics for infections, and painkillers are among the most frequently counterfeited. Many of these fake products contain incorrect dosages, inactive fillers, or dangerous contaminants that can cause immediate harm or long-term organ damage.
In rural areas, the problem is even worse. Regulatory bodies rarely conduct inspections outside major cities, creating ideal conditions for counterfeiters to sell their products unchecked. “In my village, you can buy antibiotics from a grocery shop,” said a patient from Rajshahi, who later developed severe kidney problems. “No one checks where the medicine comes from or whether it is genuine.”
A Tragedy Repeated: This is not the first time Bangladesh has suffered from the deadly effects of adulterated medicine. In the late 1980s, the country witnessed one of its worst public health disasters when more than 2,000 children died of kidney and liver failure after consuming paracetamol syrup contaminated with harmful chemicals. That incident shocked the nation and led to promises of reform - but more than three decades later, the problem persists, arguably on an even larger scale.
Since then, public health authorities have introduced various policies intended to curb the sale of fake medicines, but experts say implementation has been patchy at best. “We have strong laws on paper,” said a former Drug Administration inspector, “but without political will and proper monitoring, laws mean very little.”
Unknown Death Toll: Determining the full impact of counterfeit medicines on public health is nearly impossible. There is no official database tracking how many people die from consuming fake drugs, and in most cases, the cause of death is recorded simply as organ failure or disease progression.
However, doctors working in kidney and cancer treatment centers say the number of patients presenting with complications that could be linked to counterfeit drugs has increased dramatically in recent years. “We see patients whose conditions worsen rapidly despite treatment - and when we investigate, we find they have been taking substandard or fake medication,” said Professor Dr. Harun Or Rashid, President of the Kidney Foundation.
According to Dr. Rashid, counterfeit medicines are a significant contributor to the growing number of kidney failure patients in Bangladesh. “This is one of the main reasons we are seeing an increase in dialysis cases every year,” he warned. How the Syndicate Operates: Investigations reveal that the criminal network behind the counterfeit trade uses sophisticated methods to disguise their products. They replicate packaging so precisely that even trained pharmacists can struggle to tell the difference without laboratory testing. The fakes often carry forged batch numbers and expiration dates to pass visual inspections.
Many of these products are manufactured in unregistered factories, often in unhygienic conditions. Raw materials of dubious origin - sometimes industrial chemicals - are mixed and processed without quality control. From there, the goods are shipped to wholesalers, who distribute them nationwide.
Insiders say the Mitford market plays a central role in this process, acting as a hub where counterfeit goods are traded alongside legitimate products. Because the market supplies pharmacies across the country, even reputable stores can unwittingly end up selling fake medicines. Public Health at Risk: The human cost of this illicit trade is immense. For diabetic patients, counterfeit insulin can mean uncontrolled blood sugar, leading to blindness, kidney failure, and death. For those with infections, fake antibiotics can not only fail to treat the illness but also contribute to the dangerous rise of antibiotic-resistant bacteria.
Children are especially vulnerable. Pediatricians report cases where fake fever-reducing syrups have delayed treatment for serious illnesses, resulting in life-threatening complications. Cancer patients, too, are at risk, as counterfeit chemotherapy drugs offer no therapeutic benefit while exposing patients to toxic side effects.
Calls for Urgent Action: Doctors, pharmacists, and public health advocates are unanimous in their call for urgent, decisive measures to combat the crisis. Proposed steps include: Nationwide inspections of pharmacies to ensure compliance with licensing laws.
Severe legal penalties - including lengthy prison sentences - for those caught manufacturing or selling counterfeit medicines. Targeted criminal investigations into syndicates, wholesalers, and any complicit government officials. Public awareness campaigns to help consumers recognize suspicious products. Stronger quality control at points of import, manufacture, and distribution.
“Without a coordinated, nationwide effort, this crisis will only worsen,” said Dr. Rashid. “We cannot allow criminal greed to dictate whether a patient lives or dies.”
Restoring Trust in Healthcare: Beyond the immediate health risks, the prevalence of fake medicines undermines public trust in the healthcare system. Patients who lose faith in prescribed treatments may delay seeking medical help or turn to unsafe alternative remedies, compounding the public health threat.
Experts warn that rebuilding this trust will require not just stricter enforcement but also greater transparency. “The public needs to know that the medicines they are buying are safe, genuine, and effective,” said a senior health policy analyst.
A Crisis That Demands Political Will: Ultimately, the battle against counterfeit medicines is not just a technical challenge - it is a political one. Tackling it will require confronting entrenched interests, rooting out corruption, and investing in regulatory infrastructure. For now, however, the counterfeit trade continues to thrive, feeding on weak enforcement, corrupt networks, and public ignorance. Unless decisive action is taken, experts fear that the death toll will keep rising, turning what is already a severe public health crisis into a national catastrophe.
